On May 16, 2026, Wuhan Optics Valley – the 2026 Mindray Core Supplying Partner Conference was held at Mindray Medical's Wuhan R&D Base.

The onference, themed "Resilience for the Future, Intelligent Global Supply Chain," brought together over 200 global core suppliers, industry experts, and partners to explore cutting-edge trends in medical technology and new paths for supply chain collaboration.

Beijing Dacheng Biotechnology Co., Ltd. (hereinafter referred to as "Dacheng Biotechnology") successfully won the title of "2025 Global Outstanding Partner" from Mindray Medical, becoming a core strategic partner in Mindray Medical's in-vitro diagnostic reagent raw materials field, thanks to its excellent product quality, strong technical strength, stable delivery capabilities, and high-quality service guarantees.

This award elevates Dacheng Biotechnology to a level of core IVD raw material supplier on par with top industry suppliers such as Roche and Toyobo within Mindray's supplier system.

Standing out from stringent standards, awarded as Mindray Medical 2025 Global Outstanding Partner.

Mindray Medical, a leading global supplier of medical devices and solutions, boasts a global supply chain. Its supplier admission and rating standards are known for their stringent, comprehensive, and dynamic nature, assessing suppliers across multiple dimensions, including technological strength, product quality, delivery efficiency, cost control, service capabilities, and compliant operations. The "2025 Global Outstanding Partner" award is given by Mindray's supply chain administrators to core partners with strong overall capabilities, outstanding collaborative performance, and long-term strategic value.

This recognition is not only a high affirmation of Mindray Medical's comprehensive biological strength but also a significant milestone for both parties in deepening their strategic cooperation and jointly building a high-quality development of the medical supply chain.

Deepening Strategic Cooperation, Jointly Drawing a New Blueprint for the Healthcare Industry

Becoming Mindray Medical's "2025 Global Outstanding Partner" is not only an honor for Dacheng Biotechnology, but also a responsibility and a driving force. In the future, Dacheng Biotechnology will take this recognition as an opportunity to continue its deep cultivation in the field of in vitro diagnostic reagent raw materials, adhere to the corporate philosophy of "seeking truth and being pragmatic, pursuing excellence, and achieving win-win cooperation," increase R&D investment, break through key core technologies, and continuously improve product quality and service levels.